Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma
Clinical trial NCT03801668 · UNKNOWN
Trial details
- NCT number
- NCT03801668
- Sponsor
- Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-08
- Primary completion
- 2022-12-31
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.